Par Drugs And Chemicals Ltd. (PAR) Share Price Rises 18.45% Today

Par Drugs And Chemicals Ltd. traded at Rs 139, up Rs 21.65 or 18.45% from the previous close of Rs 117.35. The stock opened at Rs 120, touched Rs 139.89 intraday, and recorded a low of Rs 118.52. Turnover stood at Rs 2.97 crore, while market capitalisation was Rs 144.39 crore.

The move makes Par Drugs And Chemicals Ltd. Share Price one of the sharper same-day gainers in the session. However, the supplied dataset does not identify a confirmed company-specific trigger. That means the most reliable way to read today’s rise is through verified price action, valuation and profitability data rather than speculation.

On that basis, the stock trades at a P/E of 9.96 and P/B of 1.24, while ROE is 14.47% and ROCE is 19.51%. In the same-industry Pharmaceuticals & Drugs benchmark, those valuation multiples are below industry medians, while the return ratios are above median levels. That combination helps explain why Par Drugs And Chemicals Ltd. Share Price is drawing attention today.

Par Drugs And Chemicals Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 139
Previous Close	Rs 117.35
Today's Move	Rs 21.65 (+18.45%)
Open	Rs 120
High	Rs 139.89
Low	Rs 118.52
Turnover	Rs 2.97 crore
Market Capitalisation	Rs 144.39 crore
Market Cap Category	Micro Cap

Par Drugs And Chemicals Ltd. (PAR) rose to Rs 139 from the previous close of Rs 117.35, a move of Rs 21.65 or 18.45%. The stock opened at Rs 120, reached a high of Rs 139.89, recorded a low of Rs 118.52.

Par Drugs And Chemicals Ltd. Share Price rose from Rs 117.35 to Rs 139, a gain of Rs 21.65 or 18.45%. The stock opened at Rs 120 and traded in a day range of Rs 118.52 to Rs 139.89.

The session was notable for two reasons. First, the stock stayed well above the previous close and finished close to the intraday high. Second, turnover of Rs 2.97 crore shows there was active value participation behind the move. For a company with a market cap of Rs 144.39 crore, such a same-day rise naturally puts the counter on traders’ watchlists.

The clean takeaway is simple: the stock posted a strong upward session, but the dataset only confirms the move itself, not the reason behind it. Readers tracking Par Drugs And Chemicals Ltd. Share Price should separate verified market data from assumptions about a catalyst.

Par Drugs And Chemicals Ltd. (PAR) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 144.39 crore
P/E Ratio	9.96x
P/B Ratio	1.24x
ROE	14.47%
ROCE	19.51%
EPS	Rs 11.78
Book Value Per Share	Rs 94.84
Dividend Yield	0%

Par Drugs And Chemicals Ltd. (PAR) fundamental metrics show P/E 9.96x, P/B 1.24x, ROE 14.47%, ROCE 19.51%. These figures provide context only and are not a buy or sell signal.

Par Drugs And Chemicals Ltd. has a market capitalisation of Rs 144.39 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 9.96x, P/B at 1.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.47% and ROCE of 19.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 11.78, book value per share of Rs 94.84, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	9.96x
Benchmark Median P/E	30.92x
Benchmark Average P/E	48.02x
Benchmark P/E Range	3.87x to 667.16x
Company P/B Ratio	1.24x
Benchmark Median P/B	2.88x
Company ROE	14.47%
Benchmark Median ROE	11.81%
Company ROCE	19.51%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 144.39 crore
Benchmark Median Market Cap	Rs 683.05 crore

Par Drugs And Chemicals Ltd. (PAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Par Drugs And Chemicals Ltd. (PAR) has a P/E ratio of 9.96x, which is below the benchmark median of 30.92x, a difference of -67.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Par Drugs And Chemicals Ltd. (PAR) has a ROE of 14.47%, which is above the benchmark median of 11.81%, a difference of +22.52%. Par Drugs And Chemicals Ltd. (PAR) has a ROCE of 19.51%, which is above the benchmark median of 13.65%, a difference of +42.93%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,60,696.31	38.8	5.43	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,062.83	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,91,515.22	86.82	21.1	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,18,403.7	25.69	4.3	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.94	3.25	11.83	16

Par Drugs And Chemicals Ltd. (PAR) has a P/E ratio of 9.96x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.47% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.51% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Par Drugs And Chemicals Ltd. (PAR) has a market capitalisation of Rs 144.39 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Par Drugs And Chemicals Ltd.

• Strong session: the stock gained Rs 21.65, or 18.45%, to Rs 139.
• Near day high: it touched Rs 139.89 after opening at Rs 120.
• Active trading value: turnover was Rs 2.97 crore.
• Lower valuation: P/E 9.96 and P/B 1.24 are below same-industry medians.
• Above-median returns: ROE 14.47% and ROCE 19.51% are above industry medians.

About Par Drugs And Chemicals Ltd.

Par Drugs And Chemicals Ltd. operates in Healthcare and is classified under Pharmaceuticals & Drugs. Based on the supplied market data, it is a much smaller listed player than the large benchmark names commonly used for comparison in the pharma space. With a market cap of Rs 144.39 crore, the company sits below the same-industry median market cap of Rs 683.05 crore.

That context matters because smaller companies can attract outsized attention when the stock moves sharply in a single session. Today’s rise has brought Par Drugs And Chemicals Ltd. Share Price into focus, but the most grounded way to evaluate that move remains the combination of price action, relative valuation and profitability metrics already discussed above.

Track Par Drugs And Chemicals Ltd. Share Price on Univest

Use Par Drugs And Chemicals Ltd. (PAR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can follow Par Drugs And Chemicals Ltd. Share Price on the Par Drugs And Chemicals Ltd. (PAR) live share-price page. For broader market context, investors can also use the Univest top gainers screener and Univest market blogs.

These pages help users review live price updates, valuation ratios, market-cap context, peer comparison and related stock-market coverage in one place.

Frequently Asked Questions

Why is Par Drugs And Chemicals Ltd. Share Price rising today?

Ans. The stock is up 18.45% today, rising from Rs 117.35 to Rs 139. The supplied data confirms the price move, but it does not provide a verified company-specific catalyst. The previous close was Rs 117.35.

What is Par Drugs And Chemicals Ltd. Share Price today?

Ans. Par Drugs And Chemicals Ltd. Share Price is Rs 139 in this update. The stock opened at Rs 120, hit a low of Rs 118.52 and touched a high of Rs 139.89.

How do the valuations compare with the industry?

Ans. The company trades at P/E 9.96 versus the same-industry median of 30.92, and at P/B 1.24 versus the median of 2.88. That places it below the supplied industry valuation medians.

How profitable is the company versus its industry benchmark?

Ans. ROE is 14.47% versus the industry median of 11.81, and ROCE is 19.51% versus the industry median of 13.65. On the supplied data, both return ratios are above median industry levels.

What is the market capitalisation of Par Drugs And Chemicals Ltd.?

Ans. The company’s market capitalisation is Rs 144.39 crore. That is below the same-industry median market cap of Rs 683.05 crore. The company operates in the Healthcare sector. Its P/E ratio is 9.96x.